Skip to main content
Clinical Trials/NCT01244152
NCT01244152
Completed
Phase 2

Lifestyle Improvement Through Food and Exercise (LIFE): Self-Management in African Americans With Diabetes and Hypertension

Rush University Medical Center1 site in 1 country59 target enrollmentJuly 2008
ConditionsDiabetes

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes
Sponsor
Rush University Medical Center
Enrollment
59
Locations
1
Primary Endpoint
Weight change
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The primary aim of the study is to design a group-based, culturally appropriate self-management skills training intervention for disadvantaged African-Americans with both diabetes and hypertension and to compile an intervention Manual of Operations (MOO). The investigators are developing an intervention to assist individuals in reducing weight and hemoglobin A1c.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
July 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of type 2 diabetes mellitus (HgA1c\>7%), requiring the patient to take at least one tablet per day or one insulin injection per day and a diagnosis of hypertension (130/80) requiring them to take at least one medication per day;
  • Participants must identify themselves as African-American;
  • Participant resides in or proximal to the North Lawndale neighborhood;
  • Secure written permission from their physician to engage in moderate physical activity. This set of participants may be at high risk for cardiac disease and this exclusion avoids putting them at undue risk;
  • Participant must be overweight because the main goal of our intervention is weight loss of 5% or more of initial body weight.

Exclusion Criteria

  • Diet-controlled diabetes;
  • Hypertension controlled with lifestyle modification only;
  • Endstage renal disease, stroke with paresis, congestive heart failure (NYHA class 3 or 4), or other major endorgan complication of diabetes;
  • Comorbid conditions limiting probable life span to \<4 years (e.g. cancer, AIDS) or indication of end-stage complications of diabetes (kidney dialysis, or transplant, blindness, or lower extremity amputation);
  • Receiving treatment for a major psychiatric disorder (i.e. schizophrenia);
  • Unable to give informed consent;
  • Are under the age of 18-While type-2 diabetes and hypertension are increasing in those under the age of 18, adolescent medicine is a separate specialty area from adult medicine. Interventions should be targeted specifically toward this age group to take into consideration the specific emotional and psychological needs of adolescents;
  • Alcoholism as measured by the CAGE.screener for alcohol abuse.

Outcomes

Primary Outcomes

Weight change

Secondary Outcomes

  • Hemoglobin A1C

Study Sites (1)

Loading locations...

Similar Trials